via Genetic Engineering and Biotechnology News
Understanding how drugs work is an important step in developing new treatments for COVID-19, says U of A virologist
A group of University of Alberta researchers who have discovered why the drug remdesivir is effective in treating the coronaviruses that cause Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS) expect it might also be effective for treating patients infected with the new COVID-19 strain.
“Even if you know a drug works, it can be a red flag if you don’t know how it works,” said virologist Matthias Götte. “It is reassuring if you know exactly how it works against the target.
“We know the drug works against different coronaviruses, like MERS and SARS, and we know the novel coronavirus is very similar to SARS. So I would say I’m cautiously optimistic that the results our team found with remdesivir and MERS will be similar with COVID-19.”
The study, published in the Journal of Biological Chemistry this week, is among the first in Canada to discuss the COVID-19 strain.
Until now, there has not been a published explanation of why remdesivir may work against coronaviruses, said Götte, who added his study is an important step in answering that question.
Developed by Gilead Sciences as a response to the 2014 West African Ebola virus epidemic, remdesivir was first used on a patient with the novel coronavirus earlier this year in the United States.
As reported in the New England Journal of Medicine, the patient was given the drug on the seventh day of illness, and showed marked improvement the following day, with symptoms eventually disappearing altogether. And at a recent press conference in Beijing, the assistant director-general of the World Health Organization, Bruce Alyward, said remdesivir is the only drug available that may have real efficacy against COVID-19.
“What our study showed was that remdesivir essentially mimics one of the natural building blocks for RNA synthesis necessary for genome replication of the virus. Enzymes within the virus are synthesizing the viral RNA genome with these building blocks, but they mix up the bits they need with the drug. Once the drug is incorporated into the growing RNA chain, the virus can no longer replicate,” explained Götte.
He said the next step is to wait for results from ongoing clinical trials with remdesivir, which are expected by the end of April. Even then, that won’t be the end of the story, he cautioned.
“It’s likely we’ll need more than one drug to properly fight emerging diseases like COVID-19, as we have with HIV and hepatitis C virus infections,” Götte said.
“Ideally, we will have a couple of drugs because certain strains could be resistant to certain treatments.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
COVID-19
- US records record daily increase of variant cases; Florida lags in vaccinations of oldest residents; 513K US deaths. Latest COVID-19 updateson March 1, 2021 at 1:56 am
California Native American leaders fear deaths in their communities have been undercounted. US reports record increase in variants. Latest virus news.
- China to provide Afghanistan with 400,000 doses of COVID-19 vaccineon March 1, 2021 at 1:42 am
China has pledged to deliver 400,000 doses of Sinopharm's COVID-19 vaccine to Afghanistan, Afghan officials said on Monday, in a boost for an immunisation campaign begun last week.
- Turkey emerges from COVID-19-hit 2020 with 1.8% economic growthon March 1, 2021 at 1:30 am
Turkey's economy grew 5.9% in the fourth quarter https://tmsnrt.rs/3dVombP and 1.8% in 2020 as a whole, annual data showed on Monday, emerging as one of only a few globally to avoid a contraction due ...
- 'Safest place in the city': COVID-19 cases in nursing homes drop 89% as residents get vaccinatedon March 1, 2021 at 1:15 am
Even as the virus slows nationwide, nursing home cases have dropped at a faster pace than COVID-19 infections overall, a USA TODAY analysis shows.
- Arab Americans, deemed 'white' in government records, suffer an unseen COVID-19 crisison February 28, 2021 at 11:11 pm
Arab American leaders report alarming rates of COVID-19 deaths in their communities but don't have data because most are categorized as "white." ...
Go deeper with Google Headlines on:
COVID-19
Go deeper with Bing News on:
Coronaviruses
- US records record daily increase of variant cases; Florida lags in vaccinations of oldest residents; 513K US deaths. Latest COVID-19 updateson March 1, 2021 at 1:56 am
California Native American leaders fear deaths in their communities have been undercounted. US reports record increase in variants. Latest virus news.
- China to provide Afghanistan with 400,000 doses of COVID-19 vaccineon March 1, 2021 at 1:42 am
China has pledged to deliver 400,000 doses of Sinopharm's COVID-19 vaccine to Afghanistan, Afghan officials said on Monday, in a boost for an immunisation campaign begun last week.
- Turkey emerges from COVID-19-hit 2020 with 1.8% economic growthon March 1, 2021 at 1:30 am
Turkey's economy grew 5.9% in the fourth quarter https://tmsnrt.rs/3dVombP and 1.8% in 2020 as a whole, annual data showed on Monday, emerging as one of only a few globally to avoid a contraction due ...
- US begins rollout of Johnson & Johnson coronavirus vaccineon March 1, 2021 at 1:23 am
Johnson & Johnson commenced the rollout of its one-dose coronavirus vaccine Monday to distribution centers and pharmacies across the country.
- 'Safest place in the city': COVID-19 cases in nursing homes drop 89% as residents get vaccinatedon March 1, 2021 at 1:15 am
Even as the virus slows nationwide, nursing home cases have dropped at a faster pace than COVID-19 infections overall, a USA TODAY analysis shows.